PAMU
NGNE icon

Pictet Asset Management (UK)’s Neurogene NGNE Stock Holding History

Pictet Asset Management (UK)’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$18.9M Buy
102,195
+1,784
+2% +$395K 0.02% 536
2021
Q1 		$24.7M Sell
100,411
-817
-0.8% -$209K 0.03% 462
2020
Q4 		$28.5M Sell
101,228
-1,836
-2% -$449K 0.04% 416
2020
Q3 		$24.7M Buy
103,064
+18,522
+22% +$4.49M 0.04% 394
2020
Q2 		$28.1M Buy
84,542
+53,482
+172% +$13.9M 0.05% 339
2020
Q1 		$7.07M Buy
+31,060
New +$6.39M 0.02% 552

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pictet Asset Management (UK)'s NGNE Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Neurogene (NGNE) stake by 1.8% in Q2 2021, buying an estimated $395K and bringing the position to 102,195 shares worth $18.9M. The position accounts for 0.02% of the portfolio, ranked #536.

Pictet Asset Management (UK) first reported a position in NGNE in Q1 2020 and has held it in 6 quarters since. The position peaked at $28.5M in Q4 2020. 82 funds tracked by Wall St. Rank hold NGNE as of Q2 2021.

  • Pictet Asset Management (UK) held 102,195 shares of Neurogene worth $18.9M as of Q2 2021.
  • Pictet Asset Management (UK) bought 1,784 Neurogene shares in Q2 2021, an estimated $395K.
  • Neurogene made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #536 holding.
  • Pictet Asset Management (UK) first reported a position in Neurogene in Q1 2020 and has held it in 6 quarters since.
  • Pictet Asset Management (UK)'s Neurogene position peaked at $28.5M in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Neurogene as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.